Bridging Brain Barriers

Group Members

Prof. Dr. Markus Schwaninger, Wiebke Brandt, Ines Stölting, Joanna Kosinska, Nina Feller, Ümit Özorhan, Adriana Arruluo Pereira, Micha Pense, Jascha Schumann, Raoul Strasburger, Riccardo Costalunga, Surya Rai, Manon Rivagorda, Teresa Faupel, Phillip Ehrich, Guanhua Nie

Research Interests

The brain depends on the supply of nutrients by other tissues. Vice versa, it controls all bodily functions. Therefore, a close interaction between the central nervous system and the periphery is required. In addition to classical communication channels provided by afferent and efferent nerve fibers, there is an exchange of messengers and metabolites at the interfaces of brain and periphery. The latter encompass the blood-brain barrier, the blood-CSF barrier and, less known, the tanycytic barrier between circumventricular organs and brain parenchyma. Our group investigates the structure and function of these barriers. Bridging brain barriers could be a key principle in the treatment of brain diseases.

Selected recent references

Rhein S, Costalunga R, Inderhees J, Gürtzgen T, Faupel TC, Shaheryar Z, Arrulo Pereira A, Othman A, Begemann K, Binder S, Stölting I, Dorta V, Nawroth PP,  Fleming T, Oexle K, Prevot V, Nogueiras R, Meyhöfer S, Meyhöfer SM, Schwaninger M. The reactive pyruvate metabolite dimethylglyoxal mediates neurological consequences of diabetes. Nat Commun 15, 5745 (2024). doi.org/10.1038/s41467-024-50089-3

Denes A, Hansen CE, Oezorhan U, Figuerola S, de Vries HE, Sorokin L, Planas AM, Engelhardt B, Schwaninger M. Endothelial cells and macrophages as allies in the healthy and diseased brain. Acta Neuropathol. 2024 Feb 12;147(1):38. doi: 10.1007/s00401-024-02695-0.

Sundaram SM, Arrulo Pereira A, Müller-Fielitz H, Köpke H, De Angelis M, Müller TD, Heuer H, Körbelin J, Krohn M, Mittag J, Nogueiras R, Prevot V, Schwaninger M. Gene therapy targeting the blood-brain barrier improves neurological symptoms in a model of genetic MCT8 deficiency. Brain. 2022 Aug 5:awac243.